What is the ticker symbol for Autolus Therapeutics?

Autolus Therapeutics trades under the ticker AUTL on NASDAQ.

What sector does Autolus Therapeutics operate in?

Autolus Therapeutics is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze AUTL in a portfolio?

PortView shows AUTL's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

Autolus Therapeutics (AUTL) Stock Analysis

NASDAQHealthcareBiotechnology

$2.28-1.42%

1-year price historyRange $1.21 – $2.54

52-week range$2.28

$1.18$2.58

What Autolus Therapeutics does

Autolus Therapeutics plc is a clinical-stage biopharmaceutical entity primarily focused on pioneering T-cell-based immunotherapies for various oncological conditions. The company's pipeline includes several investigational programs: obecabtagene autoleucel (AUTO1), a CD19-targeting programmed T cell therapy, is currently undergoing Phase 1b/2 trials for adult acute lymphoblastic leukemia (ALL). Additionally, AUTO1/22 is in a Phase 1 study for pediatric patients experiencing relapsed or refractory ALL. Autolus is also advancing AUTO4, a programmed T cell therapy designed to target TRBC1 for the treatment of peripheral T-cell lymphoma, and AUTO8, a product candidate currently in Phase I clinical trials for multiple myeloma. In earlier development, AUTO6NG, a programmed T cell therapy, is in preclinical research targeting GD2 for neuroblastoma, and AUTO5 is another hematological product candidate in its preclinical stages. Established in 2014, Autolus Therapeutics maintains its headquarters in London, United Kingdom.

Key metrics

Market cap

$606.06M

P/E (TTM)

-2.09

EPS (TTM)

$-1.09

Beta

2.02

Dividend yield

0.00%

Revenue / share

$0.44

50-day avg

$1.84

200-day avg

$1.61

52-week high

$2.58

52-week low

$1.18

CEO

Christian Martin Itin

ETFs linked to AUTL

Broad-market and Healthcare sector ETFs an investor holding Autolus Therapeutics is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how AUTL fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze AUTL in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for Autolus Therapeutics?: Autolus Therapeutics trades under the ticker AUTL on NASDAQ.
Which exchange is AUTL listed on?: AUTL is listed on NASDAQ.
What sector does Autolus Therapeutics operate in?: Autolus Therapeutics is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze AUTL in a portfolio?: PortView shows AUTL's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.